 PURPOSE: This randomized phase III trial is studying pyridoxine and topical urealactic acid-based cream to see how well they work compared with giving pyridoxine together with a placebo, giving topical urealactic acid-based cream together with a placebo, or giving two placebos in preventing hand-foot syndrome in patients who are receiving capecitabine for breast cancer or other cancer. 